AI Article Synopsis
- - From April 2023 to May 2024, France saw a significant increase in parvovirus B19 (B19V) infections, with IgM-positive cases four times higher than in the 2019 epidemic.
- - Clinical data supported the rise, showing adverse health effects, especially in children, while adults mostly showed increased lab-confirmed cases.
- - It's crucial for physicians and policymakers to be alerted so they can improve prevention, diagnosis, and management for vulnerable patients.
Article Abstract
From April 2023 to May 2024, an unusual epidemic of parvovirus B19 (B19V) infections occurred in France. The number of B19V IgM-positive serologies was four times higher than in the previous epidemic in 2019. Clinical data from emergency networks corroborated this observation. Morbidity and mortality consequences were observed in children through all data sources. In adults, the increase was only observed in laboratory-confirmed data. Physicians and decisionmakers should be informed in order to better prevent, diagnose and manage at-risk patients.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11191415 | PMC |
| http://dx.doi.org/10.2807/1560-7917.ES.2024.29.25.2400339 | DOI Listing |
Publication Analysis
Top Keywords
parvovirus b19
8
2023 2024
8
unusual outbreak
4
outbreak parvovirus
4
b19 infections
4
infections france
4
france 2023
4
2024 april
4
april 2023
4
2024 unusual
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!